Cryo-Save to launch Cryo-Lip in the US

Cryo-Save Group N.V. (Euronext: CRYO, ´Cryo-Save´ or ´the Group´), Europe´s
leading stem cell bank, today announced that it intends to launch Cryo-Lip in the
United States in 2011, after the successful introduction of the service in
Europe during 2010.

Cryo-Save is one of the first in the world that offers cryostorage of adult
mesenchymal stem cells from fatty tissue for use by patients undergoing a
surgical procedure.

Cryo-Save is currently looking for partners to roll out this service in the
United States.

Cryo-Lip has been launched in Spain and Italy in June 2010 and has since also
been introduced in Greece, Bulgaria, Hungary and Cyprus. It will also be made
available in the Netherlands this month.

The Cryo-Lip service has been expanded thanks to new clinical developments,
which means it will be available to a much larger segment of patients.

Dr Henk Snyman, Managing Director for Cryo-Lip explained:

"Apart from the cryostorage of adult stem cells for later medical use, we can
now also release back to plastic surgeons the adipose tissue itself (Processed
LipoAspirate or PLA Liquid) for clinical applications such as lipofilling. In
addition, we have just successfully completed a pilot project, validating the
collection of adult mesenchymal stem cells from patients undergoing surgical
procedures such as elective caesarian sections, general surgical or orthopedic
operations.".

Cryo-Save has developed a novel cryopreservation process specifically for
adipose tissue, which has been submitted as an international patent. The Company
is an accredited tissue bank for the cryopreservation and storage of fatty
tissue.

Fat is the richest source of adult mesenchymal stem cells (called ASCs or
adipose-derived stem cells when harvested from fat) in the human body and
readily accessible (Gimble 2007).  Cryo-Lip requires less than 50 ml of tissue,
which can easily be obtained. ASCs are regarded as the building blocks of
regenerative medicine (Yoshimura 2008), a concept supported by recent
publications with significantly positive results in patients with acute and
chronic cardiac ischemia.

The interest from the plastic surgery community has been very high with positive
acceptance of this groundbreaking opportunity for their patients. To date the
company has registered and trained close to 100 plastic and reconstructive
surgeons as Cryo-Lip Providers who are now able to offer the service to their
patients.

Dr. Jorge Planas, an internationally renowned Plastic and Reconstructive Surgeon
in Barcelona and the Chairman of the Cryo-Lip Advisory Panel, commented:

"We are receiving positive feedback from both physicians and patients. I am
convinced that the cryopreservation of adipose tissue and adult stem cells
creates a major benefit for many and will be widely used".

 Arnoud van Tulder, the Cryo-Save CEO, added:

 "Being the first in this new market segment represents an important strategic
advantage for our company.  We are aiming for global leadership and are actively
investigating our options with regard to the introduction in the USA, the
biggest commercial market in the world".

?Websites: www.cryo-lip.com / www.cryo-save.com

?

Enquiries:

Cryo-Lip [phone]

Henk Snyman, MD, Managing [e-mail]

Cryo-Save Group + 31 (0) 575 548 998

?Arnoud van Tulder, Chief Executive Officer

?Daniel Stewart & Company plc + 44 (0) 20 7776 6550

?Chris Theis

?College Hill (UK) + 44 (0) 20 7457 2020

Rozi Morris/Adrian Duffield

?SPJ Financiële Communicatie Amstelveen (Netherlands) [phone]

?Kees Jongsma/Leon Melens

Free footage is availabla on www.videobankonline.com.

About Cryo-Save

With more than 140,000 samples saved, Cryo-Save is the leading stem cell bank in
Europe and one of the fastest growing in the world. Driven by its international
business strategy, Cryo-Save is now represented in 40 countries on three
continents with state-of-the-art processing facilities in Belgium, Germany,
Dubai, India and France (in progress). Cryo-Save Group is listed on Euronext
Amsterdam.

click here for press release in PDF:
http://hugin.info/143308/R/1472908/409379.pdf

This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.

Source: Cryo-Save Group N.V. via Thomson Reuters ONE

[HUG#1472908]

Wertpapiere des Artikels:
NL0009272137